A Study to Evaluate the Pharmacokinetics and Safety of Doripenem in Children and Adolescents with Cystic Fibrosis A Study to Evaluate the Pharmacokinetics and Safety of Doripenemin Children and Adolescents with Cys ...
An Open-Label Study to Evaluate the Single-Dose Pharmacokinetics and Safety of Doripenem in Pediatric Subjects 6 to 17 Years of age, Inclusive, With Cystic Fibrosis An Open-Label Study to Evaluate the Single-Dose Pharmacokinetics and Safety of Doripenemin Pediatric ...
Trade Name: DORIBAX Product Name: DORIBAX INN or Proposed INN: DORIPENEMHYDRATE Other descriptive name: DORIPENEMHYDRATETrade Name: DORIBAX Product Name: DORIBAX INN or Proposed INN: DORIPENEMHYDRATE Other descriptive name ...
Johnson & Johnson Pharmaceutical Research & Development L.L.C